Skip to main content


Fig. 3 | EJNMMI Research

Fig. 3

From: Targeted scVEGF/177Lu radiopharmaceutical inhibits growth of metastases and can be effectively combined with chemotherapy

Fig. 3

In kidney metastatic lesions, VEGFR-2 is expressed predominantly on CD31+ endothelial cells, while more abundant VEGFR-1 is predominantly expressed on non-endothelial cells. a Colocalization of immunofluorescent staining for CD31 (green) and VEGFR-2 (red). b VEGFR-1 (green) and VEGFR-2 (red) are expressed mostly on non-overlapping subsets of cells. Nuclei stained with DAPI (blue). ×40 objective

Back to article page